drugset / Trial / NCT01187862

Pharmacokinetic Study to Investigate Low-dose Combinations of a Cocktail of Seven Drugs for Simultaneous Phenotyping of Cytochromes

NCT01187862

Phase 1 Completed 16 enrolled University Hospital, Basel, Switzerland
RandomizedCrossoverOpen-labelDiagnostic

Summary

The purpose of this study is to assess whether a cocktail of seven approved drugs (so-called "Basel cocktail") can be used for simultaneous phenotyping of CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP2E1 and CYP3A4.

Timeline

Start
2010-07
Primary completion
2011-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Caffeine Small molecule
Background Chlorzoxazone Small molecule
Background Efavirenz Other / unclassified
Background Losartan Other / unclassified
Background Metoprolol Other / unclassified
Background Midazolam Small molecule
Background Omeprazole Other / unclassified

Indications

No indication recorded.